Observational studyAmerican journal of hematology2019

Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY.

Rüdiger Hehlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.